what are klow peptides Blend KLOW 80mg UK Research Blend

about 3.2 mg total residual

Our priority is always patient safety and transparencyif you are interested in peptide therapies or pain management options, we invite you to schedule a consultation to discuss what is safe, effective, and available for your individual needs

Mechanism Ipamorelin selectively activates the ghrelin receptor on pituitary somatotrophs, producing a brief pulse of growth hormone release without significant activation of ACTH, cortisol, prolactin, FSH, LH, or TSH pathways distinguishing it from earlier GHRPs (GHRP-2, GHRP-6) which show off-target endocrine effects

Target range is the upper-normal or slightly above reference range